MRI in Multiple Myeloma: Analysis of the Axial Skeleton Versus Whole Body. What is the Required Analysis? (MYMO)

Centre Hospitalier Universitaire de Nīmes

Status: Terminated

Conditions: Myeloma

Treatments: Diagnostic Test: MRI

Study type: Observational

Funder types: Other

Identifiers

NCT03618212

AOIGCSMERRIL/2016/AL-01

Details and patient eligibility

About

The investigators wish to determine which anatomic regions need to be explored in order to correctly diagnose myeloma: whether axial skeletal MRI alone is sufficient or whether it is necessary to perform a total skeletal MRI.

Enrollment: 12 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• The patient must have given their free and informed consent and signed the consent form
• The patient must be a member or beneficiary of a health insurance plan
• The patient is at least 18 years old
• Patient has been diagnosed with multiple myeloma (> 10% medullary plasma cells + monoclonal protein) or symptomatic myeloma (myeloma + CRAB symptoms (hypercalcemia, renal failure, anemia, bone lesions), or indolent myeloma (myeloma with symptomatic criteria).

Exclusion criteria

• The subject refuses to sign the consent
• It is impossible to give the subject informed information
• The patient is under safeguard of justice or state guardianship
• The patient is pregnant or breast feeding
• The patient has an absolute contra-indication for MRI (pace-maker, claustrophobic patient, metal heart valve)

Trial design

12 participants in 1 patient group

Myeloma patients

Treatment:

Diagnostic Test: MRI